<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet href="https://www.accessdata.fda.gov/spl/stylesheet/spl.xsl" type="text/xsl"?>
<document xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="urn:hl7-org:v3" xsi:schemaLocation="urn:hl7-org:v3 https://www.accessdata.fda.gov/spl/schema/spl.xsd">
   <id root="339e5a5d-c05d-2125-e063-6294a90aebc3"/>
   <code code="34391-3" codeSystem="2.16.840.1.113883.6.1" displayName="HUMAN PRESCRIPTION DRUG LABEL"/>
   <title>
      <content styleCode="bold">Erythromycin
  <br/>
Ophthalmic
  <br/>
Ointment
  <br/>
USP
  <br/>
0.5% 
 </content>
      <br/>
(Sterile)
 <br/>
      <br/>
      <content styleCode="bold">Rx only</content>
   </title>
   <effectiveTime value="20250425"/>
   <setId root="c49ad63b-c2fd-4535-bec0-6415c93cf847"/>
   <versionNumber value="13"/>
   <author>
      <time/>
      <assignedEntity>
         <representedOrganization>
            <id root="1.3.6.1.4.1.519.1" extension="829572556"/>
            <name>REMEDYREPACK INC.</name>
         </representedOrganization>
      </assignedEntity>
   </author>
   <component>
      <structuredBody>
         <component>
            <section>
               <id root="339e6500-864f-2d87-e063-6294a90a11ab"/>
               <code code="48780-1" codeSystem="2.16.840.1.113883.6.1" displayName="SPL product data elements section"/>
               <effectiveTime value="20250425"/>
               <subject>
                  <manufacturedProduct>
                     <manufacturedProduct>
                        <code code="70518-0465" codeSystem="2.16.840.1.113883.6.69"/>
                        <name>Erythromycin</name>
                        <formCode code="C42966" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="OINTMENT"/>
                        <asEntityWithGeneric>
                           <genericMedicine>
                              <name>Erythromycin</name>
                           </genericMedicine>
                        </asEntityWithGeneric>
                        <asEquivalentEntity classCode="EQUIV">
                           <code code="C64637" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                           <definingMaterialKind>
                              <code code="24208-910" codeSystem="2.16.840.1.113883.6.69"/>
                           </definingMaterialKind>
                        </asEquivalentEntity>
                        <ingredient classCode="IACT">
                           <ingredientSubstance>
                              <code code="4T6H12BN9U" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>PETROLATUM</name>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="IACT">
                           <ingredientSubstance>
                              <code code="T5L8T28FGP" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>MINERAL OIL</name>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="ACTIB">
                           <quantity>
                              <numerator unit="mg" value="5"/>
                              <denominator unit="g" value="1"/>
                           </quantity>
                           <ingredientSubstance>
                              <code code="63937KV33D" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>ERYTHROMYCIN</name>
                              <activeMoiety>
                                 <activeMoiety>
                                    <code code="63937KV33D" codeSystem="2.16.840.1.113883.4.9"/>
                                    <name>ERYTHROMYCIN</name>
                                 </activeMoiety>
                              </activeMoiety>
                           </ingredientSubstance>
                        </ingredient>
                        <asContent>
                           <quantity>
                              <numerator value="3.5" unit="g"/>
                              <denominator value="1"/>
                           </quantity>
                           <containerPackagedProduct>
                              <code/>
                              <formCode code="C42794" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="TUBE"/>
                              <asContent>
                                 <quantity>
                                    <numerator value="1" unit="1"/>
                                    <denominator value="1"/>
                                 </quantity>
                                 <containerPackagedProduct>
                                    <code code="70518-0465-0" codeSystem="2.16.840.1.113883.6.69"/>
                                    <formCode code="C43182" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="CARTON"/>
                                 </containerPackagedProduct>
                                 <subjectOf>
                                    <marketingAct>
                                       <code code="C53292" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                                       <statusCode code="active"/>
                                       <effectiveTime>
                                          <low value="20170426"/>
                                       </effectiveTime>
                                    </marketingAct>
                                 </subjectOf>
                              </asContent>
                           </containerPackagedProduct>
                           <subjectOf>
                              <characteristic>
                                 <code code="SPLCMBPRDTP" codeSystem="2.16.840.1.113883.1.11.19255"/>
                                 <value code="C112160" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="Type 0: Not a Combination Product" xsi:type="CV"/>
                              </characteristic>
                           </subjectOf>
                        </asContent>
                     </manufacturedProduct>
                     <subjectOf>
                        <approval>
                           <id extension="ANDA064067" root="2.16.840.1.113883.3.150"/>
                           <code code="C73584" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="ANDA"/>
                           <author>
                              <territorialAuthority>
                                 <territory>
                                    <code code="USA" codeSystem="2.16.840.1.113883.5.28"/>
                                 </territory>
                              </territorialAuthority>
                           </author>
                        </approval>
                     </subjectOf>
                     <subjectOf>
                        <marketingAct>
                           <code code="C53292" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                           <statusCode code="active"/>
                           <effectiveTime>
                              <low value="20170426"/>
                           </effectiveTime>
                        </marketingAct>
                     </subjectOf>
                     <consumedIn>
                        <substanceAdministration>
                           <routeCode code="C38287" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="OPHTHALMIC"/>
                        </substanceAdministration>
                     </consumedIn>
                  </manufacturedProduct>
               </subject>
            </section>
         </component>
         <component>
            <section ID="ID_a8ca13f3-b233-4184-8903-fe5272019d8b">
               <id root="339e5a5d-c05e-2125-e063-6294a90aebc3"/>
               <code code="34089-3" codeSystem="2.16.840.1.113883.6.1" displayName="DESCRIPTION SECTION"/>
               <title>DESCRIPTION

 <content styleCode="italics"/>
               </title>
               <text>
                  <paragraph>Erythromycin ophthalmic ointment, USP belongs to the macrolide group of antibiotics. The sterile ophthalmic ointment flows freely over the conjunctiva. Erythromycin base, as crystals or powder, is slightly soluble in water, moderately soluble in ether, and readily soluble in alcohol or chloroform. Erythromycin is an antibiotic produced from a strain of
 
  <content styleCode="italics">Streptomyces erythraeus</content>. It is basic and readily forms a salt when combined with an acid. It has the following structural formula:

 </paragraph>
                  <renderMultiMedia ID="id772901200" referencedObject="ID_1d3ff894-f574-4444-8903-3ad6cdf7c563"/>
                  <table width="100%">
                     <col width="50%"/>
                     <col width="49%"/>
                     <tbody>
                        <tr styleCode="Toprule">
                           <td valign="top">
                              <paragraph>Molecular Formula: C
     
      <sub>37</sub>H
     
      <sub>67</sub>NO
     
      <sub>13</sub>
                              </paragraph>
                           </td>
                           <td align="right" valign="top">
                              <paragraph>Mol. Wt. 733.94</paragraph>
                           </td>
                        </tr>
                     </tbody>
                  </table>
                  <paragraph>Chemical Name: ((3R
 
  <sup>●</sup>,4S
 
  <sup>●</sup>,5S
 
  <sup>●</sup>,6R
 
  <sup>●</sup>,7R
 
  <sup>●</sup>,9R
 
  <sup>●</sup>,11R
 
  <sup>●</sup>,12R
 
  <sup>●</sup>,13S
 
  <sup>●</sup>,14R
 
  <sup>●</sup>)-4-[(2,6-dideoxy-3-
 
  <content styleCode="italics">C</content>-methyl-3-
 
  <content styleCode="italics">0</content>-methyl-α-L-
 
  <content styleCode="italics">ribo</content>-hexopyranosyl)oxy]-14-ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-6-[[3,4,6-trideoxy-3-(dimethylamino)-
 
  <content styleCode="italics">β</content>-D-
 
  <content styleCode="italics">xylo</content>-hexopyranosyl]oxy]oxacyclotetradecane-2,10-dione) 
  <br/>
                  </paragraph>
                  <paragraph>Each gram contains: Active: erythromycin USP, 5 mg (0.5%); Inactives: mineral oil and white petrolatum.</paragraph>
               </text>
               <effectiveTime value="20250425"/>
               <component>
                  <observationMedia ID="ID_1d3ff894-f574-4444-8903-3ad6cdf7c563">
                     <text>ChemStructure</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="ChemStructure.jpg"/>
                     </value>
                  </observationMedia>
               </component>
            </section>
         </component>
         <component>
            <section ID="ID_6f48fb30-c875-4041-b60b-bf66aef814c9">
               <id root="339e5a5d-c05f-2125-e063-6294a90aebc3"/>
               <code code="34090-1" codeSystem="2.16.840.1.113883.6.1" displayName="CLINICAL PHARMACOLOGY SECTION"/>
               <title>CLINICAL PHARMACOLOGY</title>
               <text>
                  <paragraph>
                     <content styleCode="bold">Microbiology</content>
                  </paragraph>
                  <paragraph>Erythromycin inhibits protein synthesis without affecting nucleic acid synthesis. Erythromycin is usually active against the following organisms in vitro and in clinical infections:
 
  <content styleCode="italics">Streptococcus pyogenes</content>(group A β-hemolytic), Alpha-hemolytic streptococci (viridans group);
 
  <content styleCode="italics">Staphylococcus aureus,</content>including penicillinase-producing strains (methicillin-resistant staphylococci are uniformly resistant to erythromycin);
 
  <content styleCode="italics">Streptococcus pneumoniae;</content>
                     <content styleCode="italics">Mycoplasma pneumoniae</content>(Eaton Agent, PPLO);
 
  <content styleCode="italics">Haemophilus influenzae</content>(not all strains of this organism are susceptible at the erythromycin concentrations ordinarily achieved);
 
  <content styleCode="italics">Treponema pallidum; Corynebacterium diphtheriae; Neisseria gonorrhoeae; Chlamydia trachomatis</content>.

 </paragraph>
               </text>
               <effectiveTime value="20250425"/>
            </section>
         </component>
         <component>
            <section ID="ID_27cf6991-a675-4c41-ab30-5dd370eb408b">
               <id root="339e5a5d-c060-2125-e063-6294a90aebc3"/>
               <code code="34067-9" codeSystem="2.16.840.1.113883.6.1" displayName="INDICATIONS &amp; USAGE SECTION"/>
               <title>INDICATIONS AND USAGE</title>
               <text>
                  <paragraph>For the treatment of superficial ocular infections involving the conjunctiva and/or cornea caused by organisms susceptible to erythromycin.</paragraph>
                  <paragraph>For prophylaxis of ophthalmia neonatorum due to
 
  <content styleCode="italics">N. gonorrhoeae</content>or
 
  <content styleCode="italics">C. trachomatis</content>.

 </paragraph>
                  <paragraph>The effectiveness of erythromycin in the prevention of ophthalmia caused by penicillinase-producing
 
  <content styleCode="italics">N. gonorrhoeae</content>is not established.

 </paragraph>
                  <paragraph>For infants born to mothers with clinically apparent gonorrhea, intravenous or intramuscular injections of aqueous crystalline penicillin G should be given: a single dose of 50,000 units for term infants or 20,000 units for infants of low birth weight. Topical prophylaxis alone is inadequate for these infants.</paragraph>
               </text>
               <effectiveTime value="20250425"/>
            </section>
         </component>
         <component>
            <section ID="ID_db95bccb-8098-4d21-bbd5-692dc4d37838">
               <id root="339e5a5d-c061-2125-e063-6294a90aebc3"/>
               <code code="34070-3" codeSystem="2.16.840.1.113883.6.1" displayName="CONTRAINDICATIONS SECTION"/>
               <title>CONTRAINDICATIONS</title>
               <text>
                  <paragraph>This drug is contraindicated in patients with a history of hypersensitivity to erythromycin.</paragraph>
               </text>
               <effectiveTime value="20250425"/>
            </section>
         </component>
         <component>
            <section ID="ID_9c14f9de-e8df-4faa-bf38-c08bd4510d42">
               <id root="339e5a5d-c062-2125-e063-6294a90aebc3"/>
               <code code="42232-9" codeSystem="2.16.840.1.113883.6.1" displayName="PRECAUTIONS SECTION"/>
               <title>PRECAUTIONS</title>
               <text>
                  <paragraph>
                     <content styleCode="bold">General</content>
                  </paragraph>
                  <paragraph>The use of antimicrobial agents may be associated with the overgrowth of non-susceptible organisms including fungi; in such a case, antibiotic administration should be stopped and appropriate measures taken.</paragraph>
                  <paragraph>
                     <content styleCode="bold">
                        <content styleCode="italics">Information for Patients:</content>
                     </content>Avoid contaminating the applicator tip with material from the eye, fingers, or other source.

 </paragraph>
                  <paragraph>
                     <content styleCode="bold">
                        <content styleCode="italics">Carcinogenesis, Mutagenesis, Impairment of Fertility:</content>
                     </content>Two year oral studies conducted in rats with erythromycin did not provide evidence of tumorigenicity. Mutagenicity studies have not been conducted.

 </paragraph>
                  <paragraph>No evidence of impaired fertility that appeared related to erythromycin was reported in animal studies.</paragraph>
                  <paragraph>
                     <content styleCode="bold">
                        <content styleCode="italics">Pregnancy:</content>
                     </content>Reproduction studies have been performed in rats, mice, and rabbits using erythromycin and its various salts and esters, at doses that were several multiples of the usual human dose. No evidence of harm to the fetus that appeared related to erythromycin was reported in these studies. There are, however, no adequate and well-controlled studies in pregnant women. Because animal reproductive studies are not always predictive of human response, the erythromycins should be used during pregnancy only if clearly needed.

 </paragraph>
                  <paragraph>
                     <content styleCode="bold">
                        <content styleCode="italics">Nursing Mothers:</content>
                     </content>Caution should be exercised when erythromycin is administered to a nursing woman.

 </paragraph>
                  <paragraph>
                     <content styleCode="bold">
                        <content styleCode="italics">Pediatric Use:</content>
                     </content>See
 
  <content styleCode="bold">
                        <linkHtml href="#ID_27cf6991-a675-4c41-ab30-5dd370eb408b">INDICATIONS AND USAGE</linkHtml>
                     </content>and
 
  <content styleCode="bold">
                        <linkHtml href="#ID_ae5b9af6-4da5-45d0-a99a-a8b7396be26f">DOSAGE AND ADMINISTRATION</linkHtml>
                     </content>.

 </paragraph>
               </text>
               <effectiveTime value="20250425"/>
            </section>
         </component>
         <component>
            <section ID="ID_43553c65-6e59-40ea-9782-fd4bea0ea171">
               <id root="339e5a5d-c063-2125-e063-6294a90aebc3"/>
               <code code="34084-4" codeSystem="2.16.840.1.113883.6.1" displayName="ADVERSE REACTIONS SECTION"/>
               <title>ADVERSE REACTIONS</title>
               <text>
                  <paragraph>The most frequently reported adverse reactions are minor ocular irritations, redness, and hypersensitivity reactions.</paragraph>
                  <paragraph>
                     <content styleCode="bold">To report SUSPECTED ADVERSE REACTIONS, contact Bausch &amp; Lomb Incorporated at 1-800-553-5340 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.</content>
                  </paragraph>
               </text>
               <effectiveTime value="20250425"/>
            </section>
         </component>
         <component>
            <section ID="ID_ae5b9af6-4da5-45d0-a99a-a8b7396be26f">
               <id root="339e5a5d-c064-2125-e063-6294a90aebc3"/>
               <code code="34068-7" codeSystem="2.16.840.1.113883.6.1" displayName="DOSAGE &amp; ADMINISTRATION SECTION"/>
               <title>DOSAGE AND ADMINISTRATION</title>
               <text>
                  <paragraph>In the treatment of superficial ocular infections, erythromycin ophthalmic ointment approximately 1 cm in length should be applied directly to the infected eye(s) up to six times daily, depending on the severity of the infection.</paragraph>
                  <paragraph>For prophylaxis of neonatal gonococcal or chlamydial ophthalmia, a ribbon of ointment approximately 1 cm in length should be instilled into each lower conjunctival sac. The ointment should not be flushed from the eye following instillation. A new tube should be used for each infant.</paragraph>
               </text>
               <effectiveTime value="20250425"/>
            </section>
         </component>
         <component>
            <section ID="ID_82c57a21-6d4f-49ee-90f1-5c6debc8264f">
               <id root="339e5a5d-c065-2125-e063-6294a90aebc3"/>
               <code code="34069-5" codeSystem="2.16.840.1.113883.6.1" displayName="HOW SUPPLIED SECTION"/>
               <title>HOW SUPPLIED</title>
               <text>
                  <paragraph>Erythromycin ophthalmic ointment USP, 0.5% is available in the following sizes:</paragraph>
                  <paragraph>3.5 g (1/8 oz) in a tamper-resistant tube</paragraph>
                  <paragraph/>
                  <paragraph>NDC: 70518-0465-00</paragraph>
                  <paragraph>PACKAGING: 1 in 1 CARTON, 3.50 mg in 1 TUBE TYPE 0</paragraph>
                  <paragraph/>
                  <paragraph>Storage:Store between 15°C to 25°C (59°F to 77°F).</paragraph>
                  <paragraph>Keep out of reach of children.</paragraph>
                  <paragraph/>
                  <paragraph/>
                  <paragraph>Repackaged and Distributed By:</paragraph>
                  <paragraph>Remedy Repack, Inc.</paragraph>
                  <paragraph>625 Kolter Dr. Suite #4 Indiana, PA 1-724-465-8762</paragraph>
                  <paragraph/>
               </text>
               <effectiveTime value="20250425"/>
            </section>
         </component>
         <component>
            <section ID="id_link_339e6968-6f18-0811-e063-6394a90a48f8">
               <id root="339e6968-6f17-0811-e063-6394a90a48f8"/>
               <code code="51945-4" codeSystem="2.16.840.1.113883.6.1" displayName="PACKAGE LABEL.PRINCIPAL DISPLAY PANEL"/>
               <text>
                  <paragraph>DRUG: Erythromycin</paragraph>
                  <paragraph>GENERIC: Erythromycin</paragraph>
                  <paragraph>DOSAGE: OINTMENT</paragraph>
                  <paragraph>ADMINSTRATION: OPHTHALMIC</paragraph>
                  <paragraph>NDC: 70518-0465-0</paragraph>
                  <paragraph>PACKAGING: 3.5 g in 1 TUBE</paragraph>
                  <paragraph>OUTER PACKAGING: 1 in 1 CARTON</paragraph>
                  <paragraph>ACTIVE INGREDIENT(S):</paragraph>
                  <list listType="unordered">
                     <item>ERYTHROMYCIN 5mg in 1g</item>
                  </list>
                  <paragraph>INACTIVE INGREDIENT(S):</paragraph>
                  <list listType="unordered">
                     <item>PETROLATUM</item>
                     <item>MINERAL OIL</item>
                  </list>
                  <paragraph>
                     <renderMultiMedia referencedObject="Remedy_Label"/>
                  </paragraph>
               </text>
               <effectiveTime value="20250425"/>
               <component>
                  <observationMedia ID="Remedy_Label">
                     <text>Remedy_Label</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="Remedy_Label.jpg"/>
                     </value>
                  </observationMedia>
               </component>
            </section>
         </component>
      </structuredBody>
   </component>
</document>